株式会社リプロセル

Acquired

ReproCELL Incorporated is primarily engaged in the development of stem cell technologies.

What it does

"ReproCELL Incorporated is a leading medtech company specializing in stem cell technologies for preclinical and clinical research. Offering a wide range of products and services, REPROCELL supports Mesenchymal Stem Cell (MSC) research with ready-to-ship products, including iPSC-derived cell lines, media, and culture reagents. Their expertise extends to Research Stem Cell Services, Clinical Stem Cell Services, Clinical Gene Editing, Precision Medicine, Preclinical & Drug Discovery CRO, Clinical Laboratory Services, Human Tissue Samples, and Genomic Services. Committed to regulatory compliance, REPROCELL provides GMP iPSC Master Cell Banks and cells for cell therapy projects, ensuring quality and safety. With a focus on innovative solutions and cutting-edge technology, REPROCELL continues to drive advancements in stem cell research and drug development, making significant contributions to the medtech industry."

Its site says now · captured 2026-08-23

REPROCELL: A Global Clinical and Preclinical Research Company

Stem cell and drug discovery scientists around the world use our solutions to translate their research in to therapies.

Next to it in Healthcare and bio · Stem cell technologies and preclinical research